muramyl tripeptide phosphatidylethanolamine

Known as: muramylNAc-Ala-isoGln-Lys-tripeptide-PE, Mifamurtide, muramyl tripeptide-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine conjugate 
A liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities. Muramyl… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1968-2017
051019682017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
BACKGROUND The addition of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) to chemotherapy has been shown to… (More)
Is this relevant?
1995
1995
Two randomized, double-blind clinical trials in dogs with spontaneous appendicular osteosarcoma treated with combination… (More)
  • figure I
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1995
1995
Canine splenic hemangiosarcoma (HSA) is a spontaneous tumor with high metastatic potential. Despite surgical excision, most dogs… (More)
Is this relevant?
1995
1995
Muramyl tripeptide phosphatidylethanolamine (MTP-PE) is a synthesized lipophilic analogue of muramyl dipeptide. MTP-PE… (More)
Is this relevant?
1992
1992
PURPOSE A phase II trial that uses liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE) in patients with… (More)
Is this relevant?
1991
1991
The purpose of these studies was to determine whether chemotherapy interfered with the ability of peripheral blood monocytes from… (More)
Is this relevant?
1990
1990
Muramyl tripeptide phosphatidylethanolamine (MTP-PE; CGP 19835A from Ciba Geigy) is a synthetic muramyl tripeptide structurally… (More)
  • table 1
  • figure 1
  • table 3
  • figure 4
  • figure 2
Is this relevant?
1989
1989
Twenty-eight evaluable patients with metastatic cancer refractory to standard therapy received escalating doses of muramyl… (More)
Is this relevant?
1989
1989
This study examined the antitumor properties of blood monocytes isolated from patients undergoing a phase I trial with liposomes… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1986
1986
The purpose of these studies was to determine the optimal conditions and limitations for the eradication of spontaneous melanoma… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?